Clinical Research Directory
Browse clinical research sites, groups, and studies.
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
Sponsor: Massachusetts General Hospital
Summary
The goal of this clinical trial is to learn about the kinetic of methemoglobin in healthy subjects breathing high dose inhaled nitric oxide. The main questions it aims to answer are: * What are the kinetics of methemoglobin formation at a maximum of 300 parts per million of nitric oxide and oxygen * What are the kinetics of methemoglobin reduction after nitric oxide discontinuation Participants will be exposed to intermittent high dose inhaled nitric oxide at a maximum of 300 parts per million while being continuously monitored.
Official title: Kinetics of Methemoglobin Concentration in Healthy Subjects Exposed to High Dose Inhaled Nitric Oxide
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-10-16
Completion Date
2027-12
Last Updated
2025-12-02
Healthy Volunteers
Yes
Conditions
Interventions
Inhaled Nitric Oxide
Inhaled nitric oxide (Medical grade, in NO/N2 tanks) will be delivered in a oxygen-air-nitrogen mixture for 30 minutes three times per day
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States